Leslie Baitinger

752 total citations
9 papers, 613 citations indexed

About

Leslie Baitinger is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Animal Science and Zoology. According to data from OpenAlex, Leslie Baitinger has authored 9 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Animal Science and Zoology. Recurrent topics in Leslie Baitinger's work include Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (6 papers) and Inhalation and Respiratory Drug Delivery (6 papers). Leslie Baitinger is often cited by papers focused on Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (6 papers) and Inhalation and Respiratory Drug Delivery (6 papers). Leslie Baitinger collaborates with scholars based in United States, India and Japan. Leslie Baitinger's co-authors include Karen House, Tushar Shah, Barbara A. Prillaman, Paul Dorinsky, Gary N. Gross, James Wolfe, Craig LaForce, Martha V. White, Julian Melamed and Mani S. Kavuru and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Leslie Baitinger

8 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Baitinger United States 7 580 536 46 44 39 9 613
Wolfgang Seibold Germany 6 478 0.8× 447 0.8× 50 1.1× 19 0.4× 6 0.2× 15 528
Mark James United Kingdom 11 292 0.5× 267 0.5× 19 0.4× 13 0.3× 9 0.2× 15 372
Tito Atienza Sweden 5 566 1.0× 544 1.0× 71 1.5× 23 0.5× 17 0.4× 5 583
Tomasz Grzelewski Poland 10 270 0.5× 283 0.5× 47 1.0× 22 0.5× 5 0.1× 27 359
Richard Forth United Kingdom 11 411 0.7× 395 0.7× 18 0.4× 14 0.3× 23 0.6× 24 447
M Verini Italy 11 207 0.4× 156 0.3× 102 2.2× 14 0.3× 5 0.1× 25 302
Gail Shapiro United States 9 487 0.8× 464 0.9× 75 1.6× 59 1.3× 20 0.5× 12 541
Mena Soliman Canada 10 291 0.5× 115 0.2× 147 3.2× 12 0.3× 7 0.2× 32 355
J S Mann United Kingdom 9 163 0.3× 137 0.3× 18 0.4× 23 0.5× 9 0.2× 16 290
R.A. Nathan United States 9 338 0.6× 201 0.4× 226 4.9× 8 0.2× 7 0.2× 27 400

Countries citing papers authored by Leslie Baitinger

Since Specialization
Citations

This map shows the geographic impact of Leslie Baitinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Baitinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Baitinger more than expected).

Fields of papers citing papers by Leslie Baitinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Baitinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Baitinger. The network helps show where Leslie Baitinger may publish in the future.

Co-authorship network of co-authors of Leslie Baitinger

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Baitinger. A scholar is included among the top collaborators of Leslie Baitinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Baitinger. Leslie Baitinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bleecker, Eugene R., Steve Yancey, Leslie Baitinger, et al.. (2006). Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthma. Journal of Allergy and Clinical Immunology. 118(4). 809–816. 111 indexed citations
2.
Chipps, Bradley E., Joseph D. Spahn, Christine A. Sorkness, et al.. (2006). Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting β2-agonists. The Journal of Pediatrics. 148(4). 517–521. 21 indexed citations
3.
Stauffer, John L., Steven W. Yancey, Leslie Baitinger, Barbara A. Prillaman, & Paul Dorinsky. (2006). Measuring Airway Hyperresponsiveness: Does it Add to Routine Measures of Clinical Efficacy in Guiding Asthma Therapy?. Journal of Allergy and Clinical Immunology. 117(2). S280–S280.
4.
Murray, John, Richard R. Rosenthal, Laura L. Somerville, et al.. (2004). Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting β2-agonists. Annals of Allergy Asthma & Immunology. 93(4). 351–359. 34 indexed citations
5.
Pearlman, David S., David B. Peden, John J. Condemi, et al.. (2004). Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma. Journal of Asthma. 41(8). 797–806. 40 indexed citations
6.
Dorinsky, Paul, Steve Yancey, Leslie Baitinger, et al.. (2004). Salmeterol Response is Not Affected by Beta2-adrenergic Receptor Genotype in Patients with Persistent Asthma. CHEST Journal. 126(4). 722S–722S. 2 indexed citations
7.
Nelson, Harold S., James Wolfe, Gary N. Gross, et al.. (2003). Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administeredin a hydrofluoroalkane metered-dose inhaleras an initial asthma maintenance treatment. Annals of Allergy Asthma & Immunology. 91(3). 263–269. 30 indexed citations
8.
Shapiro, Gail, William R. Lumry, James Wolfe, et al.. (2000). Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma. American Journal of Respiratory and Critical Care Medicine. 161(2). 527–534. 176 indexed citations
9.
Kavuru, Mani S., Julian Melamed, Gary N. Gross, et al.. (2000). Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial. Journal of Allergy and Clinical Immunology. 105(6). 1108–1116. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Seibold Breakdown of academic impact, for papers by Mark James Breakdown of academic impact, for papers by Tito Atienza Breakdown of academic impact, for papers by Tomasz Grzelewski Breakdown of academic impact, for papers by Richard Forth Breakdown of academic impact, for papers by M Verini Breakdown of academic impact, for papers by Gail Shapiro Breakdown of academic impact, for papers by Mena Soliman Breakdown of academic impact, for papers by J S Mann Breakdown of academic impact, for papers by R.A. Nathan
Rankless by CCL
2026